| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |